Latest News
BY ROWLAND W. PETTIT ET AL.
Sept 2, 2021
The complex polygenic nature of lung cancer is not fully characterized. Our study seeks to identify novel phenotypes associated with lung cancer using cross-trait linkage disequilibrium score regression (LDSR).
BY MEDIAL EARLYSIGN
May 26, 2021
TEL AVIV, Israel, May 26, 2021 /PRNewswire/ -- Medial EarlySign (earlysign.com), a pioneering company developing AI-based clinical data...
BY KAVIYA SATHYAKUMAR
AUGUST 25, 2020
Lung cancer is the number one cause of cancer-related deaths in the United States as well as worldwide...
BY ELIZABETH SVOBODA
NOVEMBER 18, 2020
After years of helping to train an artificial-intelligence (AI) system to find the early stages of lung cancer, Mozziyar Etemadi was thrilled when the computer found tumours in scans of patients more accurately than trained radiologists did...
BY FOREST RAY
JULY 14, 2020
Chronic obstructive pulmonary disease (COPD) appears to be a risk factor for lung cancer, liver cancer, and colorectal cancer, regardless of smoking status, a new data study from Korea reported . . .
BY MACKENZIE BREFKA
JULY 14, 2020
Spectrum Health is now able to use new minimally invasive technology for lung biopsies, which are an important step in determining if a patient has lung cancer . . .
BY SAM BAKER
JULY 13, 2020
Texas Health Harris Methodist in Fort Worth has become the first hospital in North Texas to use a robotic-assisted technology called Ion to biopsy potential tumors earlier than traditional diagnostic tests allow . . .
BY DR. SUNIL GANDHI
JULY 13, 2020
Recently, there have been lots of new advances in the management of lung cancer. Due to these advances, patients with lung cancer are living longer and better and the death rate from lung cancer is declining every year. One such advance happened just last month . . .
BY BEN LEWIS
JULY 13, 2020
A rare type of cancer affecting the lining of the lung, malignant pleural mesothelioma (MPM) has always been very difficult to treat. That may be about to change, though. Kazuhide Sato and his colleagues at Nagoya University have found a potential new treatment . . .